The Quantellect read.As of Nov 19, 2026, 6 active firms cover Orthopediatrics Corp: 5 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $20.00 to $35.00, a moderate spread. The average target of $26.00 sits 18% below the current $31.62. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.30 next quarter toward $-0.75 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Buy
Strong Buy00%
Buy583%
Neutral117%
Sell00%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$26.00
-17.8% downside
Average target across 6 active firms as of Nov 19, 2026 vs $31.62 current
Highest Target$35.00
Average Target$26.00
Lowest Target$20.00
Detailed analyst forecasts for KIDS
Showing 1–6 of 6 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 5 of 6 active firms rate KIDS a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
KIDS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.30
Range $-0.41 – $-0.12 · 5 analysts · -29% YoY
Next period, 5 analysts expect Orthopediatrics Corp to earn $-0.30 a share (range $-0.41 – $-0.12), versus $-0.42 a year earlier. Full-year consensus is $-1.09, growing to $-0.75 the year after.
REVENUE · NEXT QUARTER
$66.9M
Range $66.0M – $69.3M · 5 analysts · +13% YoY
Revenue is expected to reach $66.9M (range $66.0M – $69.3M), +12.8% year-over-year. Full-year consensus is $271.6M, rising to $304.5M next year.
Top analysts covering Orthopediatrics Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KIDS.
#1
Ryan Zimmerman
BTIG · Rank #212
Buy
$29.00-8.3% to target
Overall win rate
37%
+ Follow
#2
Mike Matson
Needham · Rank #285
Buy
$35.00+10.7% to target
Overall win rate
36%
+ Follow
#3
David Turkaly
JMP Securities · Rank #453
Buy
$25.00-20.9% to target
Overall win rate
35%
+ Follow
#4
Richard Newitter
Truist Securities · Rank #532
Neutral
$20.00-36.7% to target
Overall win rate
30%
+ Follow
#5
Matt O'Brien
Piper Sandler · Rank #561
Buy
$25.00-20.9% to target
Overall win rate
25%
+ Follow
KIDS stock forecast FAQ
What is KIDS's average 12-month price target?+
The 6 active firms with a live target average $26.00 for Orthopediatrics Corp over the next 12 months, ranging from a $35.00 high to a $20.00 low, as of Nov 19, 2026.
Is KIDS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 6 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for KIDS?+
The Street-high target is $35.00 (Needham), and the Street-low is $20.00 (Truist Securities). The average of all 6 active-firm targets is $26.00.
How many active Wall Street firms cover KIDS?+
6 active firms have a recognized rating on Orthopediatrics Corp as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering KIDS?+
Among analysts who currently cover KIDS, Ryan Zimmerman of BTIG has the strongest overall Quantellect track record (Rank #212). Their current call is Buy with a $29.00 target.
What is Orthopediatrics Corp's projected EPS for next quarter?+
The consensus estimate is $-0.30 per share (range $-0.41 – $-0.12) across 5 analysts. Full-year EPS is projected at $-1.09, rising to $-0.75 the following year.
How much revenue is Orthopediatrics Corp expected to report next quarter?+
Consensus revenue is $66.9M (range $66.0M – $69.3M). Full-year revenue is projected at $271.6M, growing to $304.5M next year.
Have analysts been upgrading or downgrading KIDS lately?+
As of Nov 19, 2026, 5 of 6 active firms rate KIDS a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KIDS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.